Ignite Creation Date:
2025-12-24 @ 12:58 PM
Ignite Modification Date:
2025-12-31 @ 7:09 AM
Study NCT ID:
NCT01208961
Status:
COMPLETED
Last Update Posted:
2015-07-15
First Post:
2010-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-23
First Submit QC Date:
None
Study First Post Date:
2010-09-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-07-16
Results First Submit QC Date:
None
Results First Post Date:
2014-01-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-01-09
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-06-19
Last Update Post Date:
2015-07-15
Last Update Post Date Type:
ESTIMATED